scispace - formally typeset
Q

Qingzhu Jia

Researcher at Third Military Medical University

Publications -  47
Citations -  2093

Qingzhu Jia is an academic researcher from Third Military Medical University. The author has contributed to research in topics: Immunotherapy & Medicine. The author has an hindex of 15, co-authored 33 publications receiving 1279 citations.

Papers
More filters
Journal ArticleDOI

Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19

TL;DR: COVID-19 severity is associated with increased IgG response, and an immune response phenotyping based on the late IgG responded and NLR could act as a simple complementary tool to discriminate between severe and non-severe COVID- 19 patients, and further predict their clinical outcome.
Journal ArticleDOI

Clinical characteristics of 82 cases of death from COVID-19.

TL;DR: Respiratory failure is the main cause of COVID-19, but the virus itself and cytokine release syndrome-mediated damage to other organs, including cardiac, renal, hepatic, and hemorrhagic damage, should be taken seriously as well.
Journal ArticleDOI

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.

TL;DR: It is revealed that the immune microenvironment has high spatial heterogeneity such that intratumoral regional variation is as large as inter-personal variation and caution against that immunological signatures can be predicted solely from TMB or microenvironmental analysis from a single locus biopsy.
Posted ContentDOI

Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19

TL;DR: COVID-19 severity is associated with increased IgG response, and an immune response phenotyping based on late IgG responded and NLR could act as a simple complementary tool to discriminate between severe and nonsevere COVID- 19 patients, and further predict their clinical outcome.
Journal ArticleDOI

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location

TL;DR: In the TME, features of immune phenotype sidedness were identified, providing an implication for differential responses to bevacizumab/cetuximab treatment and a new avenue for innovative experimental design and combinational immunotherapy to treat CRC patients was suggested.